Previous Page  4 / 9 Next Page
Information
Show Menu
Previous Page 4 / 9 Next Page
Page Background

Volume 8, Issue 6

J Neurol Neurosci

ISSN: 2171-6625 Neuro, an open access journal

Neuroscience 2017

October 16-17, 2017

Page 13

Notes:

conference

series

.com

OCTOBER 16-17, 2017 OSAKA, JAPAN

17

TH

Global Neuroscience Conference

Leptin is essential for spinal microglia activation and the development of neuropathic pain after

preganglionic cervical root avulsion

P

reganglionic Cervical Root Avulsion (PCRA) affects both the peripheral and central nervous systems and is often associated

with neuropathic pain. Unlike Peripheral Nerve Injuries (PNI), central lesions caused by disruption of cervical roots from

the spinal cord following PCRA contribute to the generation of neuropathic pain. Leptin is involved in the development

of neuropathic pain after PNI by affecting neurons. However, whether leptin is involved in microglial activation leading to

neuropathic pain after PCRA is unknown. In this study the preganglionic avulsion of the left 6

th

-8

th

cervical roots was performed

in C57B/6J mice and leptin-deficient mice. A leptin antagonist or leptin was administered to C57B/6J mice and leptin-deficient

mice after injury, respectively. The expression pattern of spinal microglia was examined by immune-fluorescent staining. Von

Frey filaments were used to test pain sensitivity. Our data showed that leptin is essential for the development of neuropathic

pain after PCRA. Allodynia was absent in the leptin-deficient mice and the mice administered the leptin antagonist. We also

found that leptin deficiency or the administration of its antagonist inhibited the development of microgliosis, the expression

of CD86 and iNOS and Wallerian degeneration in the spinal cord. Moreover, the administration of exogenous leptin to leptin-

deficient mice reversed these effects. We concluded that leptin is involved in the proliferation and activation of microglia,

which in turn enhances the development of neuropathic pain. Blocking the effects of leptin might be a target for the treatment

of neuropathic pain after PCRA.

Biography

Ming-Chao Huang has completed his MD degree from Taipei Medical University, Taiwan in 1984 and his PhD degree from Tokyo Women’s Medical University,

Japan in 1996. He is a Neurosurgeon and is currently the Division Chief of Department of Neurosurgery, Taipei Veterans General Hospital, Taiwan. His research

interests are nerve root injury (including basic mechanism and surgical repair), neuropathic pain (including basic study and treatment) and brain tumor (including

medical and surgical treatment).

mchuang@vghtpe.gov.tw

Ming-Chao Huang

Taipei Veterans General Hospital, Taiwan

Ming-Chao Huang, J Neurol Neurosci 2017, 8:6

DOI: 10.21767/2171-6625-C1-004